Avandia press kit
Avandia (rosiglitazole maleate) was the subject of a June 2007 edition of the New England Journal of Medicine (NEJM*) about cardiovascular risk.
Veramyst press kit - 27 April 2007
GSK announces approval by the US Food and Drug Administration for Veramyst Nasal Spray.
Altabax press kit - 12 April 2007
GSK announces approval by the US Food and Drug Administration for its topical antibacterial, Altabax.
Tykerb press kit - 13 March 2007
GSK announces the approval by the FDA of Tykerb, a new targeted therapy for advanced or metastatic breast cancer.
